Novartis Pharmaceuticals Corporation et al v. Noven Pharmaceuticals Inc.
| Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd. and LTS Lohmann Therapie-Systeme AG |
| Noven Pharmaceuticals Inc. |
| 1:2013cv00527 |
| April 3, 2013 |
| US District Court for the District of Delaware |
| Wilmington Office |
| XX US, Outside State |
| Richard G. Andrews |
| Patent |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
176
Trial Opinion. Noven has failed to prove by clear and convincing evidence that claims 7 and 16 of the '031 patent are invalid as obvious. Further, the asserted claims are not invalid under obviousness-type double patenting. Novartis should submit an agreed upon form of final judgment within two weeks. Signed by Judge Richard G. Andrews on 8/31/2015. Associated Cases: 1:13-cv-00527-RGA, 1:14-cv-00111-RGA(nms)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
